Ultratech Cement is currently trading at Rs. 2421.75, up by 99.00 points or 4.26% from its previous closing of Rs. 2322.75 on the BSE.
The scrip opened at Rs. 2390.00 and has touched a high and low of Rs. 2434.00 and Rs. 2390.00 respectively. So far 18493 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2868.00 on 18-Jun-2014 and a 52 week low of Rs. 1635.00 on 14-Jan-2014.
Last one week high and low of the scrip stood at Rs. 2502.00 and Rs. 2299.55 respectively. The current market cap of the company is Rs. 66686.06 crore.
The promoters holding in the company stood at 61.69% while Institutions and Non-Institutions held 25.57% and 10.98% respectively.
UltraTech Cement has registered 55.26% rise in its net profit at Rs 410.05 crore for the quarter under review as compared to Rs 264.10 crore for the same quarter in the previous year. Total income of the company has increased 20.67% at Rs 5503.48 crore for Q2FY15 as compared Rs 4560.79 crore for the corresponding quarter previous year.
On consolidated basis, the company’s net profit after taxes and minority interest for the quarter under review registered 48.02% growth at Rs 414.24 crore against Rs 279.86 crore in the September quarter of previous fiscal. The company’s total income has increased by 18.53% at Rs 5821.48 crore for the quarter under review from Rs 4911.40 crore in the similar quarter of previous year.
In terms of the Scheme of Arrangement between Jaypee Cement Corporation (JCCL) and the company and their respective shareholders and creditors (the Scheme) 27,261 additional equity shares of the company of Rs 10 each credited as fully paid-up has been allotted to the equity shareholders of JCCL in terms of the Scheme as final consideration. The financial results of the acquired Units have been combined with the company’s financial results with effect from June 12, 2014. As a result, figures for the three months and six months ended September 30, 2014 are strictly not comparable with previous periods.